Allan Reine

Allan Reine serves as the Chief Financial Officer at Prime Medicine, Inc. since January 2024 and holds the position of Board Chair and Audit Chair at ONK Therapeutics since March 2022. Previously, Allan was the Chief Financial Officer at Foghorn Therapeutics, Inc. from September 2019 to January 2024 and at Pieris Pharmaceuticals from August 2017 to September 2019. Allan's earlier experience includes roles as Healthcare Portfolio Manager at Lombard Odier Asset Management and Portfolio Manager at Citi Principal Strategies and SAC Capital. Allan also worked as a Healthcare Long/Short at SAC Capital and was a Healthcare Portfolio Manager at Trivium Capital Management. Allan's career began as a Portfolio Manager at Alexandra Investment Management. Educational qualifications include a Doctor of Medicine from the University of Toronto and a Bachelor of Science in Statistics from Western University.